Tissue Engineering in biomaterials is a rapidly expanding sector within the global regenerative medicine market. According to Market Research Future, the tissue engineering market is predicted to reach approximately $53.2 billion by 2027, growing at a CAGR of 17.84% during 2020-2027. This growth in biomaterials is driven by technological advancements, increased prevalence of chronic diseases, and the rising geriatric population globally. Additionally, the increased investment in R&D and higher demand for organ transplantation are expected to propel the market forward. However, high costs and regulatory challenges may hinder market growth. Nevertheless, potential breakthroughs in biomaterials and stem cells present immense opportunities for this sector.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by